Introduction
The number of potential Alzheimer patients is increasing every year along with the average life expectancy, and thus ways to delay the onset are critical in order to decrease the prevalence of this devastating dementia. Although still not fully elucidated, the neuropathogenesis of Alzheimer's disease (AD), as well as other neurodegenerative diseases, begins decades before the first onset of symptoms. Genetic factors have been identified in a minority of Alzheimer patients, thus it is clear that environmental factors must play an influential role in the onset and progression of the late onset disease. Recently, a hypothesis has been advanced that exposure to inhaled general anesthetics 
